Antimicrobial Resistance and New Antimicrobial Agents, A Review of the Literature

Authors:

Abstract
Antibiotic resistance has progressively diminished the effectiveness of conventional antibiotics, necessitating the cessation of clinical treatment. Consequently, novel antibacterial agents are urgently needed. We review studies on antimicrobial agents published during 2002-2023. Most of these studies were published within the last 10 years. By analyzing recent articles on antibiotic resistance and the development of new antibacterial drugs, we showed that although drug resistance is inevitable, the issue is being addressed gradually via the discovery and clinical application of antimicrobial peptides, nanomaterial drugs, and bacteriophage therapy. In light of the emergence of antimicrobial resistance, the development of new antimicrobial agents will require innovation in a field that has relied on traditional methods of discovery and development.
Funding Information
  • National Natural Science Foundation of China (81974070)
  • Guangdong Basic and Applied Basic Research Foundation (2020A1515011063, 2023A1515011685, 2023A1-515030071)
  • Guangdong young innovative talents foundation (2020KQNCX013)
  • Shenzhen Science and Technology Program (JCYJ20210324131010027, JCYJ20220530154205011, JCYJ20230807142-314030)
  • Research Foundation of Shenzhen Hospital of Southern Medical University (23H3ATF02)

This publication has 151 references indexed in Scilit: